Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Epilepsy and Seizures: Overview01:24

Epilepsy and Seizures: Overview

293
Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
293
Inflammatory Response01:28

Inflammatory Response

8.3K
An inflammatory response is a localized, nonspecific immune reaction that occurs when a tissue is injured. It is characterized by redness, swelling, heat, and pain, which are commonly called the cardinal signs and symptoms of inflammation. Inflammation can sometimes result in a loss of function.
Inflammation can be triggered by various stimuli, such as impact, abrasion, chemical irritation, infections, and extreme hot or cold temperatures. These can damage cells and connective tissue fibers,...
8.3K
Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein01:20

Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein

459
Antiepileptic drugs, such as levetiracetam (Keppra) and brivaracetam (Briviact), have emerged as crucial tools in managing epilepsy. These medications exert their therapeutic effects by targeting the synaptic vesicle protein SV2A, a transmembrane glycoprotein primarily found in the brain.
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
459
T Cell Types and Functions01:24

T Cell Types and Functions

1.4K
When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
1.4K
Antiepileptic Drugs: GABAergic Pathway Potentiators01:18

Antiepileptic Drugs: GABAergic Pathway Potentiators

671
γ-aminobutyric acid or GABA, plays a pivotal role as an inhibitory neurotransmitter in the brain. GABA pathway potentiators, also known as GABAergic drugs, are a class of pharmaceutical agents designed to enhance the functioning of the GABAergic system. These medications primarily treat epilepsy, a neurological disorder characterized by recurrent seizures.
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
671

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Prediction and diagnosis of post-stroke epilepsy using artificial intelligence approaches: a systematic review and meta-analysis.

Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology·2026
Same author

Optical Bistability in Photonic Topological Hypercrystals and Its Applications in Photonic Neural Network.

Nanomaterials (Basel, Switzerland)·2026
Same author

Microglial GPR35 Ameliorates Epileptogenesis and Neuroinflammation via PDGFA Domain 2 Signaling.

Advanced science (Weinheim, Baden-Wurttemberg, Germany)·2026
Same author

Chronic 40 Hz light flicker mitigates epileptogenesis through a visual pathway associated with the dorsal lateral geniculate nucleus shell.

Nature communications·2025
Same author

Glymphatic system dysfunction and its impact on seizure severity, cognitive function, and affective symptoms in patients with generalized tonic-clonic seizures alone.

Journal of the neurological sciences·2025
Same author

Nanoparticles modified with glucose analogs to enhance the permeability of the blood-brain barrier and their accumulation in the epileptic brain.

Journal of materials chemistry. B·2025
Same journal

Association Between Neutrophil Percentage-to-Albumin Ratio and All-Cause Mortality and Cardiovascular Events in Patients with Diabetic Foot Ulcers: A Retrospective Cohort Study.

Journal of inflammation research·2026
Same journal

R788 is Associated with Neuroprotective Effects in Experimental Ischemic Stroke Models via Modulation of the STAT1/Nrf2/GPX4 Axis.

Journal of inflammation research·2026
Same journal

Peripheral Blood Mononuclear Cells in Sepsis: Immune Trajectories, Monocyte Dysfunction, and Translational Biomarkers.

Journal of inflammation research·2026
Same journal

PD-1/TIGIT CD4⁺ T-Cell Signature for Risk Stratification of Post-Weaning Mortality in Venoarterial Extracorporeal Membrane Oxygenation Patients.

Journal of inflammation research·2026
Same journal

Development and Validation of an Early Severity Prediction Model for Hypertriglyceridemia-Associated Acute Pancreatitis: A Multicenter Cohort Study.

Journal of inflammation research·2026
Same journal

Comparative Evaluation of Prolonged Dual Antiplatelet Therapy versus Conventional Regimens on Prognosis in Patients with High Residual Inflammatory Risk: Results from a Prospective Observational Study.

Journal of inflammation research·2026
查看所有相关文章

相关实验视频

Updated: Sep 17, 2025

Lipidomics and Transcriptomics in Neurological Diseases
09:58

Lipidomics and Transcriptomics in Neurological Diseases

Published on: March 18, 2022

3.6K

在患有慢性的患者中降低Resolvin D1和E1,这意味着神经炎症的功能障碍.

Hanli Li1,2, Zhong Dong2, Yujing Yang3

  • 1School of Clinical Medicine, Anhui Medical College, Hefei, People's Republic of China.

Journal of inflammation research
|July 2, 2025
PubMed
概括
此摘要是机器生成的。

在慢性患者中,像Resolvin D1 (RvD1) 和Resolvin E1 (RvE1) 这样的专门的亲溶解脂质调解剂 (SPMs) 降低了. 这表明炎症解决能力受损,突出显示了潜在的治疗点.

关键词:
慢性是一种慢性.这是一种炎症炎症炎症炎症.解决 D1 D1 的问题解决 E1 的问题.专门的亲溶解脂质调解剂.

更多相关视频

Determining Immune System Suppression versus CNS Protection for Pharmacological Interventions in Autoimmune Demyelination
09:38

Determining Immune System Suppression versus CNS Protection for Pharmacological Interventions in Autoimmune Demyelination

Published on: September 12, 2016

12.4K
Electroconvulsive Seizures in Rats and Fractionation of Their Hippocampi to Examine Seizure-induced Changes in Postsynaptic Density Proteins
09:07

Electroconvulsive Seizures in Rats and Fractionation of Their Hippocampi to Examine Seizure-induced Changes in Postsynaptic Density Proteins

Published on: August 15, 2017

12.2K

相关实验视频

Last Updated: Sep 17, 2025

Lipidomics and Transcriptomics in Neurological Diseases
09:58

Lipidomics and Transcriptomics in Neurological Diseases

Published on: March 18, 2022

3.6K
Determining Immune System Suppression versus CNS Protection for Pharmacological Interventions in Autoimmune Demyelination
09:38

Determining Immune System Suppression versus CNS Protection for Pharmacological Interventions in Autoimmune Demyelination

Published on: September 12, 2016

12.4K
Electroconvulsive Seizures in Rats and Fractionation of Their Hippocampi to Examine Seizure-induced Changes in Postsynaptic Density Proteins
09:07

Electroconvulsive Seizures in Rats and Fractionation of Their Hippocampi to Examine Seizure-induced Changes in Postsynaptic Density Proteins

Published on: August 15, 2017

12.2K

科学领域:

  • 神经科学是一个神经科学.
  • 免疫学 免疫学 免疫学
  • 生物化学 生化学

背景情况:

  • 炎症的解决对于保持健康至关重要.
  • 专门的亲溶解脂质调解剂 (SPMs) 是这个过程中的关键参与者.
  • 了解慢性神经疾病 (如) 中的SPM变化具有重要意义.

研究的目的:

  • 为了研究慢性患者的SPM水平.
  • 探索SPM水平和的严重程度之间的关系.
  • 为了确定慢性的炎症解决途径是否受损.

主要方法:

  • 从65名慢性患者,43名健康对照患者和43名患有非炎症神经系统疾病的患者收集了血和脑脊液 (CSF).
  • 使用液体染色学-并联质谱法 (LC-MS-MS) 量化SPM水平.
  • 使用ELISA分析了Resolvin D1 (RvD1) 和Resolvin E1 (RvE1),以及促炎因素.

主要成果:

  • 在慢性患者中观察到RvE1的血和脑液水平显著降低.
  • 与对照组相比,患者的血和脑脊液中的RvD1和RvE1水平都较低.
  • 在患者中发现有较高的炎症因子,其中RvE1与发作严重程度负相关,RvD1与认知得分相关.

结论:

  • 慢性与血和CSF中的RvD1和RvE1水平降低有关.
  • 这些发现表明,慢性发作中的炎症解消受损.
  • 向RvD1和RvE1为慢性提供了一个潜在的新疗法策略.